IMA Clinical Research is a network of clinical research sites with access to 150 satellite clinics which provides extensive, nationwide patient reach. With experienced investigators and clinicians, the network specializes in Phase II-IV, post-approval, site-based, hybrid, and fully decentralized trials across various therapeutic areas, including CNS, metabolic, vaccines, and more. IMA ensures efficient trial execution with centralized services for rapid startup—offering one budget, one contract, and streamlined regulatory submissions. The network emphasizes patient diversity, high retention, and quality care to advance the development of new medical treatments.